Letter: Decreased sensitivity to oral anticoagulant therapy after attacks of migraine.
D000284:Administration, Oral; D000925:Anticoagulants / Q000494:pharmacology*; D001778:Blood Coagulation Disorders / Q000150:complications*; D001779:Blood Coagulation Factors / Q000096:biosynthesis; D001780:Blood Coagulation Tests; D001792:Blood Platelets / Q000187:drug effects; D002536:Cerebral Arteries; D004305:Dose-Response Relationship, Drug; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007866:Leg / Q000098:blood supply; D008881:Migraine Disorders / Q000097:blood* / Q000150:complications / Q000188:drug therapy; D013924:Thrombophlebitis / Q000150:complications / Q000188:drug therapy; D014665:Vasodilator Agents / Q000494:pharmacology; D014859:Warfarin / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use
D000925:Anticoagulants; D001779:Blood Coagulation Factors; D014665:Vasodilator Agents; D014859:Warfarin; D006493:Heparin